Results 161 to 170 of about 1,159,123 (234)

Mosunetuzumab Plus Polatuzumab Vedotin in Transplant-Ineligible Refractory/Relapsed Large B-Cell Lymphoma: Primary Results of the Phase III SUNMO Trial. [PDF]

open access: yesJ Clin Oncol
Budde LE   +27 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy